BerGenBio ASA (OSL:BGBIO)
Norway flag Norway · Delayed Price · Currency is NOK
1.818
+0.118 (6.92%)
Apr 1, 2025, 3:20 PM CET

BerGenBio ASA Income Statement

Millions NOK. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2015
Revenue
0.850.350.390.770.6
Upgrade
Revenue Growth (YoY)
139.55%-9.00%-49.74%28.79%-93.25%
Upgrade
Gross Profit
0.850.350.390.770.6
Upgrade
Selling, General & Admin
37.3450.7264.3871.1452.01
Upgrade
Other Operating Expenses
114.29141.23240.76242.79208.95
Upgrade
Operating Expenses
152.08192.17306.02315.24261.69
Upgrade
Operating Income
-151.23-191.82-305.63-314.46-261.09
Upgrade
Interest Expense
-4.7-0.58-0.32-0.05-0.03
Upgrade
Interest & Investment Income
16.653.062.953.134.42
Upgrade
Other Non Operating Income (Expenses)
-0-1.060.882.02-0.33
Upgrade
Pretax Income
-139.28-190.4-302.12-309.36-257.03
Upgrade
Net Income
-139.28-190.4-302.12-309.36-257.03
Upgrade
Net Income to Common
-139.28-190.4-302.12-309.36-257.03
Upgrade
Shares Outstanding (Basic)
3514111
Upgrade
Shares Outstanding (Diluted)
3514111
Upgrade
Shares Change (YoY)
146.47%1514.80%0.77%17.40%29.10%
Upgrade
EPS (Basic)
-3.95-13.30-340.86-351.72-343.07
Upgrade
EPS (Diluted)
-3.95-13.30-340.86-351.72-343.07
Upgrade
Free Cash Flow
-153.24-225.1-288.23-303.34-234.36
Upgrade
Free Cash Flow Per Share
-4.34-15.73-325.18-344.88-312.81
Upgrade
Gross Margin
100.00%100.00%100.00%100.00%100.00%
Upgrade
Operating Margin
-17834.08%-54186.16%-78569.15%-40628.30%-43442.76%
Upgrade
Profit Margin
-16424.76%-53785.59%-77666.32%-39969.51%-42766.89%
Upgrade
Free Cash Flow Margin
-18070.99%-63587.85%-74095.37%-39191.21%-38994.51%
Upgrade
EBITDA
-150.78-191.8-305.55-314.31-260.92
Upgrade
D&A For EBITDA
0.460.020.080.150.17
Upgrade
EBIT
-151.23-191.82-305.63-314.46-261.09
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.